Curcumin analogues were evaluated for COX-2 inhibitory as anti-inflammatory activities. The designed analogues significantly enhance COX-2 selectivity. The three compounds could dock into the active site of COX-2 successfully. The binding energies of -8.2, - 7.6 and -7.5 kcal/mol were obtained for three analogues of curcumin respectively. Molecular docking study revealed the binding orientations of curcumin analogues in the active sites of COX-2 towards the design of potent inhibitors.
CITATION STYLE
Sohilait, M. R., Pranowo, H. D., & Haryadi, W. (2017). Molecular docking analysis of curcumin analogues with COX-2. Bioinformation, 13(11), 356–359. https://doi.org/10.6026/97320630013356
Mendeley helps you to discover research relevant for your work.